Inhibition of oxidation of low density lipoprotein by troglitazone

Atherosclerosis

Volumn 123, Issue 1-2, 1996, Pages 227-234

  Noguchi, Noriko ^a   Sakai, Hirokazu ^a   Kato, Yoshinori ^a   Tsuchiya, Jyunichi ^a   Yamamoto, Yuko ^a   Niki, Etsuo ^a   Horikoshi, Hiroyoshi ^b   Kodama, Tatsuhiko ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antioxidant; Free radical; Low density lipoprotein; Oxidative modification; Thiaolidine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT; PROBUCOL; THIAZOLIDINE; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029902629     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05811-X     Document Type: Article

References (36)

1. Halliwell B, Gutteridge JMC. Free Radical in Biology and Medicine, 2nd ed. Clarendon Press, Oxford, 1989.
2. Steinberg, D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Modifications of low-density lipoprotein that increase its atherogenisity. N Engl J Med 1989;320:815.
3. Doi T, Higashino K, Kurihara Y, Wada Y, Miyasaki T, Nakamura H, Uesugi S, Imanishi T, Kawabe Y, Itakura H, Yazaki Y, Matsumoto A, Kodama T. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem 1993;268:2126.
4. Niki E, Noguchi N, Gotoh N. Inhibition of oxidative modification of low density lipoprotein by antioxidants. J Nutr Sci Vitaminol 1993;39:S1.
5. Esterbauer H, Gebicki J, Puhl H, Jurgens. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13:341.
6. Niki E, Yamamoto Y, Takahashi M, Yamamoto K, Yamamoto Y, Komuro E, Miki M, Yasuda H, Mino M. Free-radical mediated damage of blood and its inhibition by antioxidants. J Nutr Sci Vitaminol 1988;34:507.
7. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 1988;85:9748.
8. Niki E, Kawakami A, Yamamoto Y, Kamiya Y. Oxidation of lipids. VIII. Synergistic inhibition of oxidation of phosphatidylcholine liposome in aqueous dispersion by vitamin E and vitamin C. Bull Chem Soc Jpn 1985;58:1971.
9. Doba T, Burton GW, Ingold KU. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta 1985;835:298.
10. Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. Biochem J 1992;288:341.
11. Noguchi N, Gotoh N, Niki E. Dynamics of the oxidation of low density lipoprotein induced by free radicals. Biochim Biophys Acta 1993;1168:348.
12. Ingold KU, Bowry VW, Stocker R, Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci 1993;90:45.
13. Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993;115:6029.
14. Suter SL, Noran JJ, Wallace P, Gumbiner B, Olefsky JM. Metabolic effect of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabates Care 1992;15:193.
15. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173.
16. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595.
17. Fujiwara T, Yoshioka S, Yoshida T, Ushiyama I, Horikoshi H. Characterization of new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988;37:1549.
18. Yoshida T, Fujita T, Kanai T, Aizawa Y, Kurumada T, Hasegawa K, Horikoshi H. Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. J Med Chem 1989;32:421.
19. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg DJ. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641.
20. Mao SJT, Yates MT, Rechtin AE, Jackson RL, Van Sickle WA. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem 1991;34:299.
21. Gotoh N, Shimizu K, Komuro E, Tsuchiya J, Noguchi N, Niki E. Antioxidant activities of probucol against lipid peroxidations. Biochim Biophys Acta 1992;1128:147.
22. Lowry OH, Rosebrough NJ, Farr AL. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265.
23. Niki E, Kamiya Y. Cage reactions of tert-butoxyl radicals. Effects of solvent and viscosity. J Am Chem Soc 1974;96:2129.
24. Niki E. Methods in Enzymology, Vol. 186. In: Packer L and Glazer AN. (eds). Academic Press, San Diego, 1991;100.
25. Esterbauer H, Striegl G, Puhl H, Rothernder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms 1989;6:67.
26. Buege JA, Aust SD. Methods Enzymol. In: Packer L and Glazer AN. (eds). Academic Press, San Diego, 1987;302.
27. Hogg N, Darley-Usmar VM, Grahȧm A, Moncada S. Peroxynitrite and atherosclerosis. Biochem Soc Trans 1993;21:358.
28. Thomas CE, Jackson RL. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharmacol Exptl Therap 1991;256:1182.
29. Yamamoto Y, Niki E, Kamiya Y. Oxidation of lipids. III. Oxidation of methyl linoleate in solution. Lipids 1982;17:870.
30. Niki E, Kawakami A, Saito M, Yamamoto Y, Tsuchiya J, Kamiya Y. Effect of phytyl side chain of vitamin E on its antioxidant activity. J Biol Chem 1985;260:2191.
31. Takahashi M, Tsuchiya J, Niki E. Scavenging of radicals by vitamin E in the membranes as studied by spin labeling. J Am Chem Soc 1989;111:6350.
32. Gotoh N, Noguchi N, Tsuchiya J, Morita K, Sakai H, Shimasaki H, Niki E, Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds. Free Rad. Res. 1996;24:123.
33. Horikoshi H, Fujiwara T, Yoshida T, Yoshioka S, Wada M, Fukami M. Pharmacological characteristics of antidiabetic agent CS-045 in diabetic animals. in Frontiers in Diabetes Research. Lessons from Animal Diabetes III. In: Shafrir E. (ed). Smith-Gordon, 1990;32.
34. Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, Shirahashi I. Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 1991;14:1083.
35. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 1992;15:193.
36. Noran JJ, Ludvik B, Beerdsen PP, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331:1188.